Invasive pulmonary aspergillosis among intubated patients with SARS-CoV-2 or influenza pneumonia

Funding Information: AR received personal fees from Maat Pharma, IML received personal fees from MSD, and Gilead. AA received personal fees from Lilly Foundation, and grants from Grifols and Fisher & Paykel. CEL received personal fees from Bayer, Merck, Aerogen, Biomérieux, ThermoFisher Brahms,...

Full description

Bibliographic Details
Main Author: the coVAPid Study Group (author)
Format: article
Language:eng
Published: 2022
Subjects:
COVID-19
Intensive care unit
Invasive pulmonary aspergillosis
Mechanical ventilation
Severe influenza
Critical Care and Intensive Care Medicine
Online Access:http://hdl.handle.net/10362/131477
Country:Portugal
Oai:oai:run.unl.pt:10362/131477

Internet

http://hdl.handle.net/10362/131477

Similar Items